---
title: "eXoZymes menjadwalkan konferensi pers kuartal II 2026 lewat webinar"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295575462.md"
description: "Exozymes Inc. has scheduled a webinar for August 20, 2026, at 17:00 ET to discuss its Q2 2026 performance updates. The company will also release its Q2 2026 press prior to the event."
datetime: "2026-08-11T20:21:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295575462.md)
  - [en](https://longbridge.com/en/news/295575462.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295575462.md)
generator: "portal-rs"
---

# eXoZymes menjadwalkan konferensi pers kuartal II 2026 lewat webinar

-   Exozymes menjadwalkan webinar pembaruan kinerja kuartal II 2026 pada Kamis, 20 Agustus 2026, pukul 17.00 ET. \* Rilis pers hasil kuartal II 2026 akan diterbitkan sebelum acara tersebut. \* Pendaftaran awal tersedia melalui here siaran langsung juga di here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exozymes Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608111610ACCESSWRNAPR\_\_\_\_\_1206289) on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [EXOZ.US](https://longbridge.com/en/quote/EXOZ.US.md)
- [ACCS.US](https://longbridge.com/en/quote/ACCS.US.md)

## Related News & Research

- [EXOZ: NCT program exceeded targets; $6M raised and $2M NIH grant secured for R&D and commercialization](https://longbridge.com/en/news/296532185.md)
- [Exozymes prices registered direct offering at USD 18 per unit, raising USD 639,990 gross](https://longbridge.com/en/news/291459539.md)
- [Exozymes wins NIH grant worth $2.03 million for cannabinoid analog development](https://longbridge.com/en/news/290734082.md)
- [Exozymes Raises $5.95 Million in Underwritten Equity Offering Led by MDB Capital](https://longbridge.com/en/news/290107775.md)
- [eXoZymes wins USD 2.03 million NIH grant for cannabinoid analog development](https://longbridge.com/en/news/290947188.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**